Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7861 to 7875 of 9006 results

  1. Minimally invasive percutaneous surgical techniques with internal fixation for correcting hallux valgus (IPG789)

    We have moved interventional procedures guidance 789 to become HealthTech guidance 723. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  2. Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (HST12)

    This guidance has been updated and replaced by NICE's highly specialised technologies guidance 34.

    Withdrawn guidance

  3. Kidney conditions: CKD and SGLT2 inhibitors (IND322)

    This indicator has been updated and replaced by NICE indicator 324.

    Withdrawn indicator

  4. Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) (TA648)

    This guidance has been updated and replaced by NICE technology appraisal guidance on dupilumab for treating severe chronic rhinosinusitis with nasal polyps (TA1134).

    Withdrawn guidance

  5. Endoluminal gastroplication for gastro-oesophageal reflux disease (IPG404)

    Interventional procedures, IPG404 - Issued: July 2011 --> This guidance has been updated and replaced by NICE HealthTech guidance 661.

    Withdrawn guidance

  6. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension (IPG418)

    Interventional procedures, IPG418 - Issued: January 2012 --> This guidance has been updated and replaced by NICE HealthTech guidance 662.

    Withdrawn guidance

  7. Heart failure: beta blockers (IND194)

    This indicator has been updated and replaced by NICE indicator 317.

    Withdrawn indicator

  8. Heart Failure: ACEi or ARBs (IND193)

    This indicator has been updated and replaced by NICE indicator 317.

    Withdrawn indicator

  9. Asthma: annual review (IND188)

    This guidance has been updated and replaced by NICE indicator 273.

    Withdrawn indicator

  10. Asthma: objective tests (IND187)

    This guidance has been updated and replaced by NICE indicator 272.

    Withdrawn indicator

  11. Diabetes: statins for secondary prevention of CVD (IND184)

    This guidance has been updated and replaced by NICE indicator 276.

    Withdrawn indicator

  12. Diabetes: statins for primary prevention of CVD (40 years and over) (IND183)

    This guidance has been updated and replaced by NICE indicator 275.

    Withdrawn indicator

  13. Diabetes: statins for primary prevention of CVD (T2DM and 10% risk) (IND182)

    This guidance has been updated and replaced by NICE indicator 274.

    Withdrawn indicator

  14. Atrial fibrillation: pulse rhythm assessment in people at risk (IND168)

    This indicator has been withdrawn following National Screening Committee recommendations and ongoing research.

    Withdrawn indicator

  15. Weight management: BMI calculation in preceding 5 years (IND167)

    This indicator has been withdrawn following discussions with the National Screening Committee.

    Withdrawn indicator